DIO Corporation (KOSDAQ:039840)
18,550
-220 (-1.17%)
Jun 27, 2025, 3:30 PM KST
DIO Corporation Revenue
DIO Corporation had revenue of 35.81B KRW in the quarter ending March 31, 2025, with 2.41% growth. This brings the company's revenue in the last twelve months to 120.49B, down -19.42% year-over-year. In the year 2024, DIO Corporation had annual revenue of 119.65B, down -23.21%.
Revenue (ttm)
120.49B
Revenue Growth
-19.42%
P/S Ratio
2.12
Revenue / Employee
253.67M
Employees
475
Market Cap
255.12B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 119.65B | -36.17B | -23.21% |
Dec 31, 2023 | 155.82B | 24.51B | 18.67% |
Dec 31, 2022 | 131.31B | -18.73B | -12.48% |
Dec 31, 2021 | 150.04B | 29.98B | 24.97% |
Dec 31, 2020 | 120.06B | -7.11B | -5.59% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 4,898.69B |
Celltrion | 3,662.23B |
ALTEOGEN | 151.65B |
Yuhan | 2,114.76B |
SK Biopharmaceuticals | 578.00B |
HLB Co., Ltd. | 74.64B |
PharmaResearch | 392.31B |
Peptron | 4.30B |